8/23/2016 | PP | Cel-Sci may raise about $5 million in registered direct sale of units
|
5/18/2016 | PP | Cel-Sci secures $5 million funds via registered direct sale of stock
|
2/17/2016 | PP | Cel-Sci completes $624,000 private placement of common-share units
|
1/14/2016 | PP | Cel-Sci raises $1.11 million through private placement of equity units
|
10/28/2015 | PP | Cel-Sci takes in $11.54 million through its public offering of units
|
10/23/2015 | PP | Cel-Sci prices $12 million public offering of units at $0.67 per unit
|
10/22/2015 | PP | Cel-Sci announces plans for public sale of its common stock, warrants
|
5/29/2015 | PP | Cel-Sci takes in $16 million through private placement of equity units
|
5/22/2015 | PP | Cel-Sci prices $16 million public offering of common stock, warrants
|
5/21/2015 | PP | Cel-Sci reports plans to sell common stock, warrants to the public
|
5/6/2015 | PP | Cel-Sci reports plans to price $35 million public sale of common stock
|
10/21/2014 | PP | Cel-Sci prices $6 million public offering of units at $0.76 per unit
|
10/20/2014 | PP | Cel-Sci reports plans to price public sale of common stock, warrants
|
4/14/2014 | PP | Cel-Sci prices $10 million public offering of units at $1.58 each
|
4/11/2014 | PP | Cel-Sci announces plans to price public sale of common stock, warrants
|
12/24/2013 | PP | Cel-Sci greenshoe fully exercised for $3.3 million public units sale
|
12/19/2013 | PP | Cel-Sci prices $3 million public offering of units at $0.63 per unit
|
12/18/2013 | PP | Cel-Sci plans to conduct public sale of common stock, warrants
|
10/11/2013 | PP | Cel-Sci greenshoe exercised for $20.5 million public offering of units
|
10/8/2013 | PP | Cel-Sci reports plans to conduct $17.83 million public sale of units
|
12/4/2012 | PP | Cel-Sci negotiates $10.5 million registered direct offering of stock
|
9/25/2012 | CVPF | Cel-Sci files $50 million shelf registration for stock and preferreds
|
6/19/2012 | PP | Cel-Sci to sell $5.6 million of stock via registered direct offering
|
1/26/2012 | PP | Cel-Sci to raise $5.76 million via registered direct offering of stock
|
12/6/2011 | PP | Cel-Sci opts to terminate $30 million at-the-market issuance agreement
|
10/4/2011 | PP | Cel-Sci to take in $4 million via registered direct offering of stock
|
11/10/2009 | CV | Cel-Sci files $40 million shelf registration for stock, preferreds
|
10/27/2009 | PP | Cel-Sci investor files suit, alleges breach of contract over convertibles
|
9/16/2009 | PP | New Issue: Cel-Sci prices $20 million registered direct offering of common shares
|
8/20/2009 | PP | New Issue: Cel-Sci plans $4.37 million registered direct offering of equity units
|
8/20/2009 | PP | Market Commentary: GTO wraps subscription sale; Poniard arranges equity financing; Cerus to raise $13.2 million
|
8/5/2009 | PP | New Issue: Cel-Sci takes in $2 million from sale of series B notes with warrants
|
7/24/2009 | CV | Cel-Sci files $10 million convertible notes, preferreds, stock shelf
|
6/30/2009 | PP | New Issue: Cel-Sci concludes $5.85 million registered direct offering of units
|
6/30/2009 | PP | Market Commentary: Rexahn to sell stock; Voxware to raise $2.5 million; Suntech secures loan; Klondex wraps deal
|
6/24/2009 | PP | New Issue: Cel-Sci arranges $5 million registered direct offering of equity units
|
6/24/2009 | PP | Market Commentary: Rentech to raise $6.4 million; Cel-Sci arranges $5 million offering; Gold One plans stock deal
|
1/6/2009 | PP | Market Commentary: Community Central raises $3.3 million; Great Lakes investor keeps stake; Cel-Sci gets equity line
|
1/6/2009 | PP | New Issue: Cel-Sci gets $5 million line of credit
|
4/19/2007 | PP | Market Commentary: Castle Brands prepares to seal $20.89 million private placement; LCC wraps $17 million stock offering
|
4/18/2007 | PP | New Issue: Cel-Sci concludes $15 million stock offering
|
4/18/2007 | PP | Market Commentary: CytRx to settle $36.98 million stock offering; Cel-Sci wraps $15 million private placement of shares
|
11/14/2006 | BT | CEL-SCI says goals include starting Multikine phase 3 clinical trial, expanding indications
|
8/7/2006 | BTPP | New Issue: Cel-Sci secures $8.3 million from sale of convertible notes
|
6/8/2006 | BT | Cel-Sci regains compliance with Amex
|
5/23/2006 | BT | Cel-Sci says Multikine improves long-term survival for head and neck cancer by 33% to 40%
|
4/20/2006 | BT | Cel-Sci, U.S. Navy extend agreement to study CEL-1000 for malaria
|
4/4/2006 | BT | CEL-SCI files patent for avian bird flu drug CEL-1000
|
3/8/2006 | BT | Cel-Sci encouraged by data from study of Multikine for cancer
|
2/28/2006 | BT | CEL-SCI awarded patent for peptide vaccine technology for autoimmune conditions, allergies
|
2/17/2006 | BT | Cel-Sci says it's out of compliance with Amex listing rules after failing to file 10-Q
|
2/10/2006 | PP | Market Commentary: Standard Uranium pockets $7 million in convertibles; Parafin wraps $6 million stock offering
|
2/10/2006 | BTPP | New Issue: Cel-Sci secures $1 million from private placement of stock
|
1/25/2006 | BT | Cel-Sci to submit plan to maintain Amex listing
|
11/1/2005 | BT | CEL-SCI issued patent on CEL-1000 to enhance immune response
|
10/31/2005 | BTPP | New Issue: Cel-Sci raises $5 million from equity line
|